Stress Dose Prednisone for Patients on 10mg Daily Baseline
For minor stress (fever, outpatient infection, minor procedures), patients already taking prednisone 10mg daily typically do NOT require additional stress dosing. 1
Clinical Decision Algorithm
Minor Stress Situations
- Fever or infection treated with antibiotics (outpatient)
- Significant emotional stress
- Minor surgery/procedures under local anesthesia
Action: Continue baseline 10mg prednisone daily—no supplementation needed 1
Rationale: The 2024 European Society of Endocrinology/Endocrine Society joint guideline explicitly states that "extra glucocorticoids are typically not needed for patients already taking predniso(lo)ne-equivalent doses ≥10mg daily" during minor stress. Your patient is already at this threshold.
Moderate to Major Stress Situations
- Severe illness requiring hospital admission
- Major trauma
- Surgery under general/regional anesthesia
- Labor, vaginal delivery, or cesarean section
Action: Switch to parenteral glucocorticoids 1
- Hydrocortisone 100mg IV at surgery start, then 200mg/24h continuous infusion
- Or equivalent doses of methylprednisolone/dexamethasone
- Continue until stress resolves
Vomiting/Diarrhea Without Hemodynamic Instability
Action: Consider parenteral glucocorticoids to prevent adrenal crisis 1
Critical caveat: Oral absorption is compromised—do not rely on oral dosing even if you would normally increase it.
Hemodynamic Instability, Vomiting, or Diarrhea
Action: Treat as suspected adrenal crisis immediately 1
- Parenteral hydrocortisone 100mg IV bolus
- Aggressive fluid resuscitation
- Do not delay treatment for diagnostic testing
Important Clinical Pitfalls
The 10mg threshold is protective: Patients on ≥10mg prednisone daily already receive supraphysiologic glucocorticoid coverage that typically suffices for minor stressors. The guideline draws a clear line at this dose 1.
Do not confuse with physiologic replacement: If this patient were on prednisone for established adrenal insufficiency (not therapeutic immunosuppression), the approach would differ. For true adrenal insufficiency, you would double the replacement dose during minor stress (equivalent to hydrocortisone 40mg daily split into divided doses) 1.
Mortality risk exists: Even with adequate baseline dosing, increased mortality occurs particularly in the immediate period after glucocorticoid cessation or during stress in patients who haven't had HPA axis testing 1. Maintain high clinical suspicion.
Individual judgment required: While the guideline provides this framework, clinical judgment remains essential 1. If your patient appears clinically unstable or has concerning symptoms despite "minor" stress, escalate to parenteral therapy.
Supporting Evidence Quality
This recommendation is based on the 2024 joint European Society of Endocrinology and Endocrine Society clinical guideline published in the Journal of Clinical Endocrinology & Metabolism 1—the most recent and authoritative guidance available. The guideline acknowledges that robust head-to-head evidence comparing different glucocorticoid regimens is lacking, and practices vary considerably among centers 1. However, the consensus expert opinion from two major endocrine societies provides the strongest available framework for clinical decision-making.
The 2020 UK guidelines from the Association of Anaesthetists, Royal College of Physicians, and Society for Endocrinology support similar principles for perioperative management 2, though the 2024 guideline supersedes these for general stress dosing recommendations.